TOPICAL TOFACITINIB: A JAK-STAT INHIBITOR FOR THE TREATMENT OF VITILIGO: A CASE REPORT
Dr. Upasana Chauhan, Dr. Aakanksha and Dr. Nita Kumari*
ABSTRACT
Vitiligo is a skin disorder characterized by loss of pigment producing cells, resulting in depigmented patches on the skin. Recent studies have shown that CD8+T cells and interferon-γ play key roles in the destruction of melanocytes in the pathogenesis of vitiligo. We reported improvement after topical tofacitinib in a male patient of vitiligo.
Keywords: .
[Full Text Article]
[Download Certificate]